Advertisement
Advertisement

HCA

HCA logo

HCA Healthcare, Inc.

426.37
USD
Sponsored
-8.82
-2.03%
May 11, 15:59 UTC -4
Closed
exchange

Pre-Market

426.04

-0.33
-0.08%

HCA Earnings Reports

Positive Surprise Ratio

HCA beat 27 of 41 last estimates.

66%

Next Report

Date of Next Report
Jul 23, 2026
Estimate for Q2 26 (Revenue/ EPS)
$19.55B
/
$7.45
Implied change from Q1 26 (Revenue/ EPS)
+2.28%
/
+4.20%
Implied change from Q2 25 (Revenue/ EPS)
+5.05%
/
+9.08%

HCA Healthcare, Inc. earnings per share and revenue

On Apr 24, 2026, HCA reported earnings of 7.15 USD per share (EPS) for Q1 26, missing the estimate of 7.21 USD, resulting in a -0.85% surprise. Revenue reached 19.11 billion, compared to an expected 19.29 billion, with a -0.96% difference. The market reacted with a -8.77% price change (close before vs. close after earnings).
Looking ahead to Q2 26, 17 analysts forecast an EPS of 7.45 USD, with revenue projected to reach 19.55 billion USD, implying an increase of 4.20% EPS, and increase of 2.28% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
Viatris Inc. Common Stock
Report Date
May 07, 2026 For Q1 26
Estimate
$0.51
Actual
$0.59
Surprise
+15.17%
logo
Charles River Laboratories International, Inc.
Report Date
May 07, 2026 For Q1 26
Estimate
$1.96
Actual
$2.06
Surprise
+4.98%
logo
PACS Group, Inc.
Report Date
May 11, 2026 For Q1 26
Estimate
$0.40
Actual
$0.50
Surprise
+22.55%
logo
Caris Life Sciences, Inc. Common Stock
Report Date
May 07, 2026 For Q1 26
Estimate
-$0.02
Actual
$0.00
Surprise
+100.00%
logo
Concentra Group Holdings Parent, Inc.
Report Date
May 07, 2026 For Q1 26
Estimate
$0.34
Actual
$0.40
Surprise
+17.03%
logo
Progyny, Inc. Common Stock
Report Date
May 07, 2026 For Q1 26
Estimate
$0.30
Actual
$0.28
Surprise
-4.89%
logo
Enhabit, Inc.
Report Date
May 13, 2026 For Q1 26
Estimate
$0.15
Actual
-
Surprise
-
logo
Omada Health, Inc. Common Stock
Report Date
May 07, 2026 For Q1 26
Estimate
-$0.08
Actual
-$0.05
Surprise
+38.88%
logo
The Oncology Institute, Inc. Common Stock
Report Date
May 07, 2026 For Q1 26
Estimate
-$0.07
Actual
-$0.02
Surprise
+74.46%
logo
SkinHealth Systems Inc. Class A Common Stock
Report Date
May 07, 2026 For Q1 26
Estimate
-$0.07
Actual
-$0.05
Surprise
+36.47%
FAQ
For Q1 2026, HCA Healthcare, Inc. reported EPS of $7.15, missing estimates by -0.85%, and revenue of $19.11B, -0.96% below expectations.
The stock price moved down -8.77%, changed from $474.03 before the earnings release to $432.46 the day after.
The next earning report is scheduled for Jul 23, 2026.
Based on 17 analysts, HCA Healthcare, Inc. is expected to report EPS of $7.45 and revenue of $19.55B for Q2 2026.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement